Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL
Condition:   Lymphoma, Mantle-Cell Interventions:   Drug: Polatuzumab vedotin;   Drug: Bendamustine Hydrochloride;   Drug: Rituximab Sponsor:   Czech Lymphoma Study Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2021 Category: Research Source Type: clinical trials

Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma
Condition:   Non-hodgkin Lymphoma,B Cell Intervention:   Drug: Azacytidine, Bendamustine and Piamprizumab Sponsor:   Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2021 Category: Research Source Type: clinical trials